Cervical lymphadenitis caused by nontuberculous mycobacteria in immunocompetent children: Clinical and therapeutic experience

Head and Neck

Volumn 20, Issue 3, 1998, Pages 245-249

  Losurdo, Giuseppe ^a   Castagnola, Elio ^a   Cristina, Emilio ^a   Tasso, Loredana ^a   Toma, Paolo ^a   Buffa, Piero ^a   Giacchino, Raffaella ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Cervical adenitis; Clarithromycin; NTM infection; Pediatric; Rifabutin

Indexed keywords

AMIKACIN; CLARITHROMYCIN; CYCLOSERINE; ETHAMBUTOL; RIFABUTIN;

ARTICLE; CERVICAL LYMPH NODE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LYMPHADENITIS; MALE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPENIA; PRIORITY JOURNAL; TREATMENT PLANNING; TUBERCULOSIS;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOCOMPETENCE; INFANT; LYMPHADENITIS; MALE; MYCOBACTERIUM INFECTIONS; RIFABUTIN;

EID: 0031895228     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199805)20:3<245::AID-HED10>3.0.CO;2-J     Document Type: Article

References (30)

1. Falkinham JO 3rd. Epidemiology of infection by nontuberculous Mycobacteria. Clin Microbiol Rev 1996;9: 177-215.
2. Schaefer WB. Serologic identification and classification of the atypical mycobacteria by their agglutination. Am Rev Respir Dis 1965;92:85-93.
3. Brooks RW, Parker BC, Guft H, et al. Epidemiology of infection by nontubercolous mycobacteria. Am Rev Respir Dis 1982;4:630-633.
4. Hsu KHK. Atypical mycobacterial infections in children (Editorial). Rev Infect Dis 1981;3:1075-1080.
5. Kiehn TE, Edwards FF, Brannon P, et al. Infections caused by Mycobacterium avium complex in immunocompromised patients. Diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol 1985;21:168-173.
6. Meisser PS, Falkinham JO 3rd. Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare and Mycobacterium scrofulaceum. J Infect Dis 1986;153:325-331.
7. Wardrop PA, Pillsbury HC 3rd: Mycobacterium avium acute mastoiditis. Arch Otolaryngol 1984;110:686-687.
8. Iseman MD, Corpe FR, O'Brien RJ, Rosenzwieg DY, Wolinsky E. National consensus conference on tubercolosis: disease due to Mycobacterium avium-intracellulare. Chest 1985;87:1395-1495.
9. Wolinnsky E. Nontuberculous mycobacteria and associated disease. Am Rev Respir Dis 1979;119:107-159.
10. Horsburgh CR, Mason VG 3rd, Farhi DC, Iseman MD. Disseminated infection with Mycobacterium avium-intracellulare: a report of 13 cases and a review of the literature. Medicine 1985;64:36-48.
11. Good RC, Snider DE. Isolation of nontuberculous mycobacteria from the United States. J Infect Dis 1982;146: 829-833.
12. Lai KK, Stottmeier KD, Sherman IH, et al. Mycobacterial cervical lymphadenopathy: relation of etiologic agents to age. JAMA 1984;251:1286-1288.
13. American Thoracic Society: Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990;142:940-955.
14. Huebner RE, Schein MF, Cauthen GM, Geiter LJ, O'Brien RJ. Usefulness of skin testing with mycobacterial antigens in children with cervical lymphadenopathy. Pediatr Infect Dis 1992;11:450-456.
15. Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases: long-term follow-up. Clin Infect Dis 1994;954-963.
16. Manolidis S, Frenkiel S, Yoskovitch A. Mycobacterial infections of the head and neck. Otolaryngol Head Neck Surg 1993:427-433.
17. Kuze F, Kurasawa T, Bando K, et al. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs. Rev Infect Dis 1981;3:885-897.
18. Wallace RJ, et al. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1973;22:229-234.
19. David HL. Basis for the lack of drug susceptibility of atypical mycobacteria. Rev Infect Dis 1981;3:878-884.
20. Ghon A. The primary lung: focus of tuberculosis in children. London: JA Churchill Ltd, 1916.
21. Ellner JJ, Goldberger MJ, Parenti DM. Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J Infect Dis 1991;163:1326-1335.
22. Heifete L. Drug susceptibility in the chemotherapy of bacterial infections. Boca Raton: CRC Press, 1991:124-127.
23. Krause PJ, Hight DW, Schwartz AN, et al. Successful management of mycobacterium intracellulare pneumonia in a child. Pediatr Infect Dis 1986;269-271.
24. Byrne SK, Geddes GL, Isaac-Renton JL, et al. Comparison of in-vitro antimicrobial susceptibilities of Mycobacterium avium-Mycobacterium intracellulare strains from patients with AIDS, without AIDS and from animal sources. Antimicrobial Agents Chemother 1985;28: 440-441.
25. Levin RH, Bolinger AM. Treatment of nontuberculous mycobacterial infections in pediatric patients. Clin Pharm 1988;7:545-551.
26. Desforges JF. Mycobacterium avium complex infection in acquired immunodeficiency syndrome. N Engl J Med 1991;324:1332-1338.
27. Hoyt L, Oleske J, Holland B, Connor E. Nontuberculous mycobacteria in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1991;11:354-360.
28. Stone AB, Schelonka RL, Drehnen DM, Mcmahon DP, Ascher DP. Disseminated Mycobacterium avium complex in non-human immunodeficiency virus-infected pediatric patients. Pediatr Infect Dis 1992;11:960-964.
29. Horsburgh CR. Advances in the prevention and treatment of Mycobacterium avium disease. N Engl J Med 1996;335: 428-429.
30. Young LS. Mycobacterial diseases in the 1990s. J Antimicrobial Chemother 1993;32:179-194.